Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrienne D Cox

Showing results (1-10 of 109) with videos related to

Pageof 11
Sort By:
Nature Chemical Biology|June 19, 2010
Protein localization: Can too much lipid glue stop Ras?Adrienne D Cox
Nature Medicine|September 5, 2015
Up-front polytherapy for ALK-positive lung cancerBingying Zhou, Adrienne D Cox
Seminars in Cancer Biology|June 29, 2004
Prenyl-binding domains: potential targets for Ras inhibitors and anti-cancer drugsYoel Kloog, Adrienne D Cox
Science (New York, N.Y.)|September 19, 2024
KRAS takes the road to destructionAdrienne D Cox, Channing J Der
Cancer Cell|February 21, 2012
The RAF inhibitor paradox revisitedAdrienne D Cox, Channing J Der
Nature Cancer|February 20, 2025
Drugging mutant KRAS by disrupting binding to effectors and GTPAdrienne D Cox, Channing J Der
Current Opinion in Pharmacology|July 20, 2002
Farnesyltransferase inhibitors: promises and realitiesAdrienne D Cox, Channing J Der
Cancer Research|November 25, 2003
Rac1 and Rac3 are targets for geranylgeranyltransferase I inhibitor-mediated inhibition of signaling, transformation, and membrane rufflingPatricia L Joyce, Adrienne D Cox
Cancer Cell|March 16, 2010
The raf inhibitor paradox: unexpected consequences of targeted drugsAdrienne D Cox, Channing J Der
Small Gtpases|June 21, 2011
Ras history: The saga continuesAdrienne D Cox, Channing J Der
Pageof 11

Showing results (1-10 of 109) with videos related to

Sort By:
Pageof 11
Nature Chemical Biology|June 19, 2010
Protein localization: Can too much lipid glue stop Ras?Adrienne D Cox
Nature Medicine|September 5, 2015
Up-front polytherapy for ALK-positive lung cancerBingying Zhou, Adrienne D Cox
Seminars in Cancer Biology|June 29, 2004
Prenyl-binding domains: potential targets for Ras inhibitors and anti-cancer drugsYoel Kloog, Adrienne D Cox
Science (New York, N.Y.)|September 19, 2024
KRAS takes the road to destructionAdrienne D Cox, Channing J Der
Cancer Cell|February 21, 2012
The RAF inhibitor paradox revisitedAdrienne D Cox, Channing J Der
Nature Cancer|February 20, 2025
Drugging mutant KRAS by disrupting binding to effectors and GTPAdrienne D Cox, Channing J Der
Current Opinion in Pharmacology|July 20, 2002
Farnesyltransferase inhibitors: promises and realitiesAdrienne D Cox, Channing J Der
Cancer Research|November 25, 2003
Rac1 and Rac3 are targets for geranylgeranyltransferase I inhibitor-mediated inhibition of signaling, transformation, and membrane rufflingPatricia L Joyce, Adrienne D Cox
Cancer Cell|March 16, 2010
The raf inhibitor paradox: unexpected consequences of targeted drugsAdrienne D Cox, Channing J Der
Small Gtpases|June 21, 2011
Ras history: The saga continuesAdrienne D Cox, Channing J Der
Pageof 11